Biofil Chemicals & Pharmaceuticals Limited has announced the closure of its trading window for designated persons, their immediate relatives, and connected persons. This closure is effective from Thursday, January 01, 2026, and will remain in effect for the purpose of considering the un-audited financial results for the quarter and nine months ended December 31, 2025. The company is adhering to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and has complied with relevant SEBI circulars regarding trading window closures. The trading window is expected to reopen 48 hours after the un-audited financial results for the aforementioned period are declared and become generally available to the public. All directors, key management personnel, designated employees, and connected persons are advised against trading in the company's securities, directly or indirectly, during this period. The company will intimate the date of the Board Meeting for the consideration of these financial results in due course. The announcement was made by Apoorv Jain, Company Secretary & Compliance Officer.